IMMX Archived Articles
Immix Biopharma (IMMX): Pioneering Cell Therapies in AL Amyloidosis and Autoimmune Diseases
Published on March 11, 2025
Immix Biopharma (NASDAQ:IMMX): A Trailblazer in Harnessing the Immune System for Groundbreaking Cures
Published on November 30, 2024
Immix Biopharma, Inc. (NASDAQ:IMMX): Pioneering Tissue-Specific Therapeutics in Oncology and Autoimmune Diseases
Published on September 24, 2024